TNTRQ yields 4000000.00% · MRK yields 2.76%● Live data
📍 TNTRQ pulled ahead of the other in Year 1
Combined, TNTRQ + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TNTRQ + MRK for your $10,000?
Tintri, Inc. develops and markets an enterprise cloud platform combining cloud management software technology and a range of all-flash storage systems for virtualized and cloud environments in the United States and internationally. The company's platform provides large organizations and cloud service providers with public cloud capabilities inside their data centers and public cloud services. Its products and technologies include Tintri CONNECT, a proprietary software architecture for virtualized and cloud applications; Tintri OS, which helps the interaction between the virtualized infrastructure and the underlying storage serving that infrastructure; Tintri Global Center, an intelligent data and system management product; and VM Scale-out software, which creates resource pools of Tintri storage systems and optimizes the location of applications. The company's products and technologies also include predictive analytics solutions for customers to model their current and future storage requirements; ReplicateVM, the replication solutions for data protection and disaster recovery; SyncVM, a solution for copy data management; SecureVM, a solution for encryption of data-at-rest; Tintri Cloud Connector, which allows customers to use public cloud storage for storing snapshots; and storage systems, such as EC6000 all-flash systems, T800 hybrid-flash systems, and T1000 all-flash system. It also offers its products related support, installation, and training services. The company serves customer in education, financial services, insurance, healthcare, manufacturing, and automotive technology, as well as cloud service providers. Tintri, Inc. was founded in 2008 and is headquartered in Mountain View, California. On July 10, 2018, Tintri, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 8, 2019.
Full TNTRQ Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.